Analyst Ratings for Ascendis Pharma (ASND)
ASND Rating Summary
ASND Price Target Summary
- Highest: $355.00 (Citi)
- Lowest: $255.00 (Goldman Sachs)
- Average: $300.82
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$300.82 (+18.5%)
* Over Last 12-Mos
Rating Score: 9.5 / 10
Percentile Rank: 91%
Rating Score: 9.5 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
295.00 (N/A) |
237.64 (253.86) |
6.83% | Details |
| 5/18/2026 | Citi | Eric Joseph | New Coverage | Buy (N/A) |
355.00 (N/A) |
240.50 (253.86) |
5.56% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
